Reflux Esophagitis

References

• Richter J E, Castell DO. Drugs, foods and other substances in the cause and treatment of reflux esophagitis. Med Clin N Am 1981; 65: 1223–1234
   PubMed Web of Science ®Google Scholar
• Tytgat G NJ, Nio CY. Medical therapy of reflux esophagitis. Bailliere's Clin Gastroenterol 1987; 1: 791–807
   PubMedGoogle Scholar
• Johnson L F, DeMeester TR. Evaluation of elevation of the head of the bed, bethanechol and antacid form tablets on gastroesophageal reflux. Dig Dis Sci 1981; 26: 673–680
   PubMed Web of Science ®Google Scholar
• Harvey R F, Gordon P C, Hadley N, Long D E, Gill T R, Macpherson R D, Beats B C, Tottle AJ. Effects of sleeping with the bed-head raised and of ranitidine in patients with severe peptic oesophagitis. Lancet 1987; 2: 1200–1203
   PubMed Web of Science ®Google Scholar
• Hamilton J W, Boisen R J, Yamamoto D T, Wagner J L, Reichelderfer M. Sleeping on a wedge diminishes exposure of the esophagus to refluxed acid. Dig Dis Sci 1988; 33: 518–522
   PubMed Web of Science ®Google Scholar
• Thomas F B, Steinbaugh T J, Fromkes J J, Mekhjian H S, Caldwell JH. Inhibitory effect of coffee on lower esophageal sphincter pressure. Gastroenterology 1980; 79: 1262–1266
   PubMed Web of Science ®Google Scholar
• Lloyd D A, Borda IT. Food-induced heartburn: effect of osmolarity. Gastroenterology 1981; 80: 740–741
   PubMed Web of Science ®Google Scholar
• Berenson M M, Sontag S, Robinson M G, McCallum R M. The GERD study group., Effect of smoking in a controlled study of ranitidine treatment in gastroesophageal reflux disease. J Clin Gastroenterol 1987; 9: 499–503
   PubMed Web of Science ®Google Scholar
• Koelz H R, Birchler R, Bretholz A, et al. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986; 91: 1198–1205
   PubMed Web of Science ®Google Scholar
• Wesdorp I CE. Treatment or reflux esophagitis. Scand J Gastroenterol 1984; 17: 106, suppl 79
   Web of Science ®Google Scholar
• Castell DO. Medical therapy for reflux esophagitis: 1986 and beyond. Ann Intern Med 1986; 104: 112–114
   PubMed Web of Science ®Google Scholar
• Verlinden M. Review article: a role for gastrointestinal prokinetic agents in the treatment of reflux esophagitis. Aliment Pharmacol Ther 1989; 3: 113–131
   PubMed Web of Science ®Google Scholar
• Rode H, Stunden R J, Millar A JW, Cywes S. Esophageal pH assessment of gastroesophageal reflux in 18 patients and the effect of two prokinetic agents: cisapride and metoclopramide. J Pediatr Surg 1987; 22: 931–934
   PubMed Web of Science ®Google Scholar
• Baldi F, Lobello R, Tittobello A, . Effect of cisapride on lesions and symptoms of reflux esophagitis. Progress in the treatment of gastro-intestinal motility disorders: the role of cisapride., AG Johnson, G Lux, et al. Excerpta Medica, Amsterdam 1988; 66–69
   Google Scholar
• Lepoutre L, Bollen J, Vandewalle N, . Therapeutic effects of the enterokinetic agent cisapride in reflux oesophagitis. A double-blind, placebo-controlled study. Progress in the treatment of gastro-intestinal motility disorders: the role of cisapride, AG Johnson, G Lux, et al. Excerpta Medica, Amsterdam 1988; 63–65
   Google Scholar
• Evreux M, Filoche B, Fournet J, et al. Endoscopic and clinical evaluation of cisapride and cimetidine in reflux oesophagitis. Gastroenterology 1988; 94: A120
   Web of Science ®Google Scholar
• Maleev A, Crowe J, Silveira J, Thomson A, et al. Cisapride and cimetidine in the treatment of erosive esophagitis. Hepatogastroenterol 1990, in press
   PubMedGoogle Scholar
• Barbosa J, Beijer B, de Freitas J, Ferreira L SA, Gautier A. Effect of twice daily administered cisapride on symptoms and on healing of lesions in patients with oesophagitis: a double-blind rani-tidine-controlled study, Interim report
   Google Scholar
• Geldof H, Otten MH, Wetzels A MH. Double-blind comparison of the efficacy of two dosage schedules of cisapride with ranitidine in patients with reflux oesophagitis. Interim report
   Google Scholar
• Janisch H, Huttemann W, Bouzo M. Cisapride versus ranitidine in the treatment of reflux esophagitis. Hepatogastroenterol 1988; 35: 125–127
   PubMedGoogle Scholar
• Galmiche J P, Brandstatter G, Evreux M, et al. Combined therapy with cisapride and cimetidine in severe reflux esophagitis: a double blind placebo-controlled trial. Gut 1988; 29: 675–681
   PubMed Web of Science ®Google Scholar
• Weiss W, Brunner H, Biittner G, et al. Therapie der Reflux-osophagitis mit Sucralfat. Deutsch Med Wochenschr 1984; 108: 1706–1711
   Web of Science ®Google Scholar
• Williams R M, Orlando R C, Bozymski E M, et al. Multicenter trial of sucralfate suspension for the treatment of reflux esophagitis. Am J Med 1987; 83: 61–66, suppl 33
   PubMed Web of Science ®Google Scholar
• Laitinen S, Stahlberg M, Kairaluoma M I, Kiviniemi H, Paakonen M, Laitinen J, Poikolainen E, Aukee S. Sucralfate and alginate/antacid in reflux esophagitis. Scand J Gastroenterol 1985; 20: 229–232
   PubMed Web of Science ®Google Scholar
• Evreux M. Sucralfate versus alginate/antacid in the treatment of peptic esophagitis. Am J Med 1987; 83: 48–50
   PubMed Web of Science ®Google Scholar
• Hameeteman W, Boomgaard DM, vd Dekker W, Schrijver M, Wesdorp I C, Tytgat G NJ. Sucralfate versus cimetidine in reflux esophagitis. A single-blind multicenter study. J Clin Gastroenterol 1987; 9: 390–394
   PubMed Web of Science ®Google Scholar
• Simon B, Dammann H G, Miiller P. Sucralfate in the treatment of reflux esophagitis in adults: an update. Scand J Gastroenterol 1989; 24: 37–41, suppl 156
   Web of Science ®Google Scholar
• Robertson D AF, Aldersley M A, Shepherd H, Lloyd R S, Smith CL. H2-antagonists in the treatment of reflux esophagitis: can physiological studies predict the response?. Gut 1987; 28: 946–949
   PubMed Web of Science ®Google Scholar
• Gudmundsson K, Joelsson B, Johnsson F. The hourly pattern of gastroesophageal reflux. Diseases of the oesophagus, JR Siewert, AH Holscher. Springer Verlag, Berlin 1987; 1062–1063
   Google Scholar
• Tytgat G NJ, Nicolai J J, Reman FC. Efficacy of different doses of cimetidine in the treatment of reflux esophagitis. Gastroenterology 1990, in press
   Web of Science ®Google Scholar
• Bovero E, Cheli R, Barbara L. Short term treatment of reflux oesophagitis with ranitidine 300 mg nocte. Italian multicentre study. Hepatogastroenterol 1987; 34: 155–159
   PubMedGoogle Scholar
• Halvorsen L, Lee F I, Wesdorp I CE, Johnson N J, Mills J G, Wood JR. Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg ranitidine at bedtime. Aliment Pharmacol Ther 1989; 3: 171–181
   PubMed Web of Science ®Google Scholar
• Berlin R, Ebel D, Cook T. Famotidine (F) 40 HS vs ranitidine (R) 150 BID in the treatment of reflux esophagitis: the results of a multicenter trial. Gastroenterology 1989; 96: A39
   Google Scholar
• Temple J G, Bradby G VH, O'Connor F, et al. Cimetidine and metoclopramide in oesophageal reflux disease. Br Med J 1983; 286: 1863–1864
   PubMed Web of Science ®Google Scholar
• Lieberman D A, Keeffe EB. Treatment of severe reflux esophagitis with cimetidine and metoclopramide. Ann Intern Med 1986; 104: 21–26
   PubMed Web of Science ®Google Scholar
• Wienbeck M. The Ranprid study group Therapeutic effect of cisapride added on to ranitidine in patients with reflux esophagitis. Dig Dis Sci 1986; 31(27S)A97
   Google Scholar
• Bianchi Porro G, Pace F, Lazzaroni M. Esophagitis healing with ranitidine. Gastroenterology 1987; 92: 2051–2052
   PubMed Web of Science ®Google Scholar
• Jansen J BMJ, Lamers C BHW. Medicamenteuze behandeling van reflux oesophagitis: effecten van sterke maagzuurremming. Ned Tijdschr Geneeskd 1989; 133: 662–665
   PubMedGoogle Scholar
• Jansen J BMJ, Baak L C, Lamers C BHW. Effect of increasing doses of ranitidine on exposure of the oesophagus to gastric acid in patients with reflux esophagitis. Scand J Gastroenterol 1988; 23: 2–5
   Web of Science ®Google Scholar
• Lehtola J, Niemela S, Martikainen J, Krekela I. Ranitidine 150 mg three times a day in the treatment of reflux oesophagitis. Scand J Gastroenterol 1986; 21: 175–180
   PubMed Web of Science ®Google Scholar
• Schaub N, Meyrick Thomas J, Misiewicz J J, Lovell D, Trotman IF. Investigation of ranitidine 150 mg b.d. or 300 mg b.d. in the treatment of reflux disease. Hepatogastroenterol 1986; 33: 208–213
   PubMedGoogle Scholar
• Johnson N J, Boyd E JS, Mills J G, Wood JR. Acute treatment of reflux oesophagitis: a multicentre trial to compare 150 mg ranitidine b.d. with 300 mg ranitidine q.d.s. Aliment Pharmacol Ther 1989; 3: 259–266
   PubMed Web of Science ®Google Scholar
• Lind T, Cederberg C, Ekenved G, Olbe L. Inhibition of basal and betazole and shamfeeding-induced acid secretion by omeprazole in man. Scand J Gastroenterol 1986; 21: 1004–1010
   PubMed Web of Science ®Google Scholar
• Hetzel D J, Dent J, Reed W D, et al. Healing and relapse of severe peptic oesophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 903–912
   PubMed Web of Science ®Google Scholar
• Dammann H G, Blum A L, Lux G, et al. Unter-schiedliche Heilungstendenz der Refluxosophagitis nach Omeprazol und Ranitidin. Deutsch Med Wochenschr 1986; 111: 123–128
   PubMedGoogle Scholar
• Haveland T, Laursen L S, Skoubo-Kristensen E. Omeprazole and ranitidine in treatment of reflux oesophagitis. Br Med J 1988; 296: 89–92
   PubMedGoogle Scholar
• Klinkenberg-Knol E C, Jansen J MBJ, Festen H PM, Meuwissen S GM, Lamers C BHW. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987; 1: 349–351
   PubMed Web of Science ®Google Scholar
• Sandmark S, Carlsson R, Fausa A, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Scand J Gastroenterol 1988; 23: 625–632
   PubMed Web of Science ®Google Scholar
• Vantrappen G, Coenegrachts J L, Rutgeerts L, Schurmans P. Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis. Dig Dis Sci 1988; 33: 523–529
   PubMed Web of Science ®Google Scholar
• Zeitoun P, Rampal P, Barbier P, et al. Omeprazole (20 mg/j) compareé à ranitidine (150 mg 2 fois/j) dans le traitement de l'oesophagite par reflux. Gastroenterol Clin Biol 1989; 13: 457–462
   PubMedGoogle Scholar
• Dehn T CB, Shepherd H A, Colin-Jones D, Kettle-Well M GW. Double blind comparative study of omeprazole (40 mg od) vs cimetidine (400 qds) in the treatment of erosive reflux oesophagitis. Gut 1988; 22: A1440
   Google Scholar
• Lundell L, Westin I H, Sandmark S, et al. Omeprazole or high dose ranitidine in the treatment of patients with reflux esophagitis not responding to standard doses of H2-receptor antagonists. Gastroenterology, 89(96)A310
   Google Scholar
• Blum A L, Wienbeck M, Schiessel R, Carlsson R. Omeprazole is superior to ranitidine in the treatment of reflux esophagitis. Hepatogastroenterol 1989; 36: 279
   Google Scholar
• Bate C M, Keeling P WN, O'Morain C A, et al. Omeprazole heals reflux oesophagitis in a greater proportion of patients than cimetidine, assessed endoscopically, histologically and symptomatically. Hepatogastroenterol 1989; 36: 279
   Google Scholar
• Klinkenberg-Knol E C, Meuwissen S GM. Is omeprazole effective in the treatment of patients with reflux esophagitis not responding to H2-receptor antagonists?. Gastroenterology 1987; 92: 1472
   Web of Science ®Google Scholar
• Festen H PM, Driessen W MM, Lamers C BH, Van Tongeren J HM. Cimetidine in the treatment of severe ulcerative reflux oesophagitis: results of an 8-week double-blind study and of subsequent long-term maintenance treatment. Neth J Med 1980; 23: 237–240
   PubMed Web of Science ®Google Scholar
• Bright-Asare P, Behar J, Brand DL. Effects of long-term maintenance cimetidine therapy on gastroesophageal reflux disease. Gastroenterology 1982; 82: 1025
   Web of Science ®Google Scholar
• Kaul B, Peterson H, Erichsen H. Gastroesophageal reflux disease: acute and maintenance treatments with cimetidine. Scand J Gastroenterol 1986; 21: 139–145
   PubMed Web of Science ®Google Scholar
• Ottenjann R, Siewert J R, Heilman K, Neiss A, Döpper H. Treatment of reflux oesophagitis. Results of a multicentre trial with cimetidine. Diseases of the oesophagus, JR Siewert, AH Holscher. Springer Verlag, Berlin 1988; 1123–1129
   Google Scholar
• Sherbaniuk R, Wensel R, Bailey R, et al. Ranitidine in the treatment of symptomatic gastroesophageal reflux disease. J Clin Gastroenterol 1984; 6: 9–15
   PubMed Web of Science ®Google Scholar
• Berlin R, Ebel D, Cook T. Famotidine (F) 20 HS & 40 HS vs Placebo (P) in the maintenance therapy (MT) of reflux esophagitis (RE). Results of a double blind, multicenter trial. Gastroenterology 1989; 96: A39
   Google Scholar
• Klinkenberg-Knol E C, Jansen J MBJ, De Bruyne J W, et al. Long-term treatment with omeprazole (OME) in resistant reflux oesophagitis: effects on endoscopic healing and fasting serum gastrin (G) levels. Gastroenterology 1988; 94: 1379
   Google Scholar
• Jones D B, Howden C W, Burget DW. A metaanalysis to define optimal dosing with antisecretory drugs. Gut 1987; 28: 1120–1127
   PubMed Web of Science ®Google Scholar
• Orr W C, Robinson M G, Humphries J J, Antonello J, Cagliola A. Dose response effect of famotidine on patterns of gastroesophageal reflux. Aliment Pharmacol Ther 1988; 2: 229–236
   PubMed Web of Science ®Google Scholar